imOxy personal page - To The Moon

imOxy

imOxy

No personal profile

22Follow

5Followers

0Topic

0Badge

2021-08-31

?

Sorry, the original content has been removed

2021-08-04

?...

Sorry, the original content has been removed

2021-08-04

?

Sorry, the original content has been removed

2021-08-04

?

Sorry, the original content has been removed

2021-08-04

?

Sorry, the original content has been removed

2021-08-01

?

SIA, SIAE, Singtel potential candidates for company restructuring: Maybank

2021-07-31

//@imOxy: ??

Sorry, the original content has been removed

2021-07-31

?

Sorry, the original content has been removed

2021-07-30

?

Sorry, the original content has been removed

2021-07-30

?

Sorry, the original content has been removed

2021-07-24

???

Sorry, the original content has been removed

2021-07-24

?....

Musk Tweets That Tesla Will Share Its Charging Network. Why That’s a Savvy Move.

2021-07-23

?

Tesla puts new Model S deliveries on hold, and it’s unclear why

2021-07-23

?

Sorry, the original content has been removed

2021-07-23

The most stable stocks

Sorry, the original content has been removed

2021-07-23

?

Sorry, the original content has been removed

2021-07-23

Hello

Sorry, the original content has been removed

2021-07-23

?

What You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":4087121361671570,"uuid":"4087121361671570","gmtCreate":1624018547780,"gmtModify":1626660093813,"name":"imOxy","pinyin":"imoxy","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":22,"tweetSize":31,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"93.14%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":818347646,"gmtCreate":1630379526185,"gmtModify":1676530286529,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/818347646","repostId":"1168575044","repostType":4,"isVote":1,"tweetType":1,"viewCount":400,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807741339,"gmtCreate":1628062200921,"gmtModify":1703500492724,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?...","listText":"?...","text":"?...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/807741339","repostId":"1126131791","repostType":4,"isVote":1,"tweetType":1,"viewCount":383,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807740620,"gmtCreate":1628061958860,"gmtModify":1703500488748,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/807740620","repostId":"2156174967","repostType":4,"isVote":1,"tweetType":1,"viewCount":459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807740949,"gmtCreate":1628061934381,"gmtModify":1703500488087,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/807740949","repostId":"1126131791","repostType":4,"isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807757918,"gmtCreate":1628061799434,"gmtModify":1703500487098,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/807757918","repostId":"2156174967","repostType":4,"isVote":1,"tweetType":1,"viewCount":426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802465066,"gmtCreate":1627797210355,"gmtModify":1703496039172,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802465066","repostId":"1153879814","repostType":4,"repost":{"id":"1153879814","pubTimestamp":1627784753,"share":"https://www.laohu8.com/m/news/1153879814?lang=&edition=full","pubTime":"2021-08-01 10:25","market":"sg","language":"en","title":"SIA, SIAE, Singtel potential candidates for company restructuring: Maybank","url":"https://stock-news.laohu8.com/highlight/detail?id=1153879814","media":"Singapore Business","summary":"Who will follow in SPH, Keppel and Sembcorp steps in corporate restructuring?\n\nDrivers are in play f","content":"<blockquote>\n <b><i>Who will follow in SPH, Keppel and Sembcorp steps in corporate restructuring?</i></b>\n</blockquote>\n<p>Drivers are in play for more corporate restructuring from Singapore firms following the major restructuring plans of Singapore Press Holdings (SPH) and a possible merger between Keppel Offshore &amp; Marine and Sembcorp Marine Ltd, according to a report by Maybank Kim Eng.</p>\n<p>According to the report, the drivers catalyzing these restructurings remain in play and are unlikely to retreat in the near-term.</p>\n<p>Some Singapore companies named by Maybank that are potential candidates for a corporate restructuring are Singtel, Singapore Airlines Group and the Singapore Institute of Aerospace Engineers.</p>\n<p>Maybank said Singtel is currently exploring options to review its stakes in associates and infrastructure assets to unlock latent value.</p>\n<p>Continued weakness and expected long lead time to recovery of international air travel may force certain rationalization for SIA and SIAE. Meanwhile, big developers like CityDev and UOL also have sizable development businesses similar to CAPL.</p>","source":"lsy1618986048053","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SIA, SIAE, Singtel potential candidates for company restructuring: Maybank</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSIA, SIAE, Singtel potential candidates for company restructuring: Maybank\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-01 10:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://sbr.com.sg/economy/news/sia-siae-singtel-potential-candidates-company-restructuring-maybank><strong>Singapore Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Who will follow in SPH, Keppel and Sembcorp steps in corporate restructuring?\n\nDrivers are in play for more corporate restructuring from Singapore firms following the major restructuring plans of ...</p>\n\n<a href=\"https://sbr.com.sg/economy/news/sia-siae-singtel-potential-candidates-company-restructuring-maybank\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"C6L.SI":"新加坡航空公司"},"source_url":"https://sbr.com.sg/economy/news/sia-siae-singtel-potential-candidates-company-restructuring-maybank","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153879814","content_text":"Who will follow in SPH, Keppel and Sembcorp steps in corporate restructuring?\n\nDrivers are in play for more corporate restructuring from Singapore firms following the major restructuring plans of Singapore Press Holdings (SPH) and a possible merger between Keppel Offshore & Marine and Sembcorp Marine Ltd, according to a report by Maybank Kim Eng.\nAccording to the report, the drivers catalyzing these restructurings remain in play and are unlikely to retreat in the near-term.\nSome Singapore companies named by Maybank that are potential candidates for a corporate restructuring are Singtel, Singapore Airlines Group and the Singapore Institute of Aerospace Engineers.\nMaybank said Singtel is currently exploring options to review its stakes in associates and infrastructure assets to unlock latent value.\nContinued weakness and expected long lead time to recovery of international air travel may force certain rationalization for SIA and SIAE. Meanwhile, big developers like CityDev and UOL also have sizable development businesses similar to CAPL.","news_type":1},"isVote":1,"tweetType":1,"viewCount":457,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802393985,"gmtCreate":1627714611747,"gmtModify":1703495141112,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"//<a href=\"https://laohu8.com/U/4087121361671570\">@imOxy</a>: ??","listText":"//<a href=\"https://laohu8.com/U/4087121361671570\">@imOxy</a>: ??","text":"//@imOxy: ??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802393985","repostId":"1138566016","repostType":4,"isVote":1,"tweetType":1,"viewCount":436,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802399728,"gmtCreate":1627714584864,"gmtModify":1703495141438,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802399728","repostId":"1138566016","repostType":4,"isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806057101,"gmtCreate":1627619512503,"gmtModify":1703493512355,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/806057101","repostId":"1158304787","repostType":4,"isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806057060,"gmtCreate":1627619489750,"gmtModify":1703493512193,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/806057060","repostId":"2155513329","repostType":4,"isVote":1,"tweetType":1,"viewCount":266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174536148,"gmtCreate":1627109311584,"gmtModify":1703484422853,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/174536148","repostId":"2153933012","repostType":2,"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174538713,"gmtCreate":1627109272932,"gmtModify":1703484421241,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?....","listText":"?....","text":"?....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/174538713","repostId":"1109439356","repostType":4,"repost":{"id":"1109439356","pubTimestamp":1627096841,"share":"https://www.laohu8.com/m/news/1109439356?lang=&edition=full","pubTime":"2021-07-24 11:20","market":"us","language":"en","title":"Musk Tweets That Tesla Will Share Its Charging Network. Why That’s a Savvy Move.","url":"https://stock-news.laohu8.com/highlight/detail?id=1109439356","media":"Barrons","summary":"This past Wednesday, Elon Musk tweeted that Tesla would open up its global network of 25,000-plus chargers to non-Tesla electric vehicles. That might seem strange, even for Musk. But it could also be savvy. “It’s brilliant,” Gary Black tells Barron’s. Former Wall Street analyst and executive Black has amassed 80,000 Twitter followers for his views on stocks, including Tesla, which he owns shares in. “We like the move,” adds Wedbush analyst Dan Ives, also a Tesla bull. He rates the stock a Buy, w","content":"<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e34edc30ae38ac91a9f953a1dcae4dbc\" tg-width=\"930\" tg-height=\"619\" width=\"100%\" height=\"auto\"><span>Illustration by Elias Stein</span></p>\n<p>This past Wednesday, Elon Musk tweeted that Tesla would open up its global network of 25,000-plus chargers to non-Tesla electric vehicles. That might seem strange, even for Musk. But it could also be savvy. “It’s brilliant,” Gary Black tells Barron’s. Former Wall Street analyst and executive Black has amassed 80,000 Twitter followers for his views on stocks, including Tesla, which he owns shares in. “We like the move,” adds Wedbush analyst Dan Ives, also a Tesla bull. He rates the stock a Buy, with a $1,000 price target. “While some will view it as letting competition in on Tesla’s supercharger moat, we disagree…”</p>\n<p>For all the competition between their makers, EVs account for less than 5% of all new cars sold in the U.S. The larger struggle remains between electric- and gasoline-powered vehicles. Anything Musk does to make buying electrics easier is good for Tesla. Besides, Tesla could make a lot of money by opening its network. Although Tesla didn’t respond to a question about potential pricing, charging won’t be free, and refusing to let others use the system would be like a gas station only servicing Fords. And charging eventually will be as ubiquitous as gas stations.</p>\n<p>Then there’s the free publicity and advertising. Opening up the charging network shows Tesla is interested in overall EV adoption and not just in selling its own vehicles. That’s positive for the brand. And it means that thousands of EV buyers will be pulling up to a Tesla logo, again and again.</p>\n<p>Investors brushed off the tweet. Tesla closed at $643.38 Friday, basically flat on the week, with earnings ahead. That’s probably right. For now, charging-for-all will probably matter more at the margins.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk Tweets That Tesla Will Share Its Charging Network. Why That’s a Savvy Move.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk Tweets That Tesla Will Share Its Charging Network. Why That’s a Savvy Move.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-24 11:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/elon-musk-tesla-charging-network-51627090559><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Illustration by Elias Stein\nThis past Wednesday, Elon Musk tweeted that Tesla would open up its global network of 25,000-plus chargers to non-Tesla electric vehicles. That might seem strange, even for...</p>\n\n<a href=\"https://www.barrons.com/articles/elon-musk-tesla-charging-network-51627090559\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/elon-musk-tesla-charging-network-51627090559","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109439356","content_text":"Illustration by Elias Stein\nThis past Wednesday, Elon Musk tweeted that Tesla would open up its global network of 25,000-plus chargers to non-Tesla electric vehicles. That might seem strange, even for Musk. But it could also be savvy. “It’s brilliant,” Gary Black tells Barron’s. Former Wall Street analyst and executive Black has amassed 80,000 Twitter followers for his views on stocks, including Tesla, which he owns shares in. “We like the move,” adds Wedbush analyst Dan Ives, also a Tesla bull. He rates the stock a Buy, with a $1,000 price target. “While some will view it as letting competition in on Tesla’s supercharger moat, we disagree…”\nFor all the competition between their makers, EVs account for less than 5% of all new cars sold in the U.S. The larger struggle remains between electric- and gasoline-powered vehicles. Anything Musk does to make buying electrics easier is good for Tesla. Besides, Tesla could make a lot of money by opening its network. Although Tesla didn’t respond to a question about potential pricing, charging won’t be free, and refusing to let others use the system would be like a gas station only servicing Fords. And charging eventually will be as ubiquitous as gas stations.\nThen there’s the free publicity and advertising. Opening up the charging network shows Tesla is interested in overall EV adoption and not just in selling its own vehicles. That’s positive for the brand. And it means that thousands of EV buyers will be pulling up to a Tesla logo, again and again.\nInvestors brushed off the tweet. Tesla closed at $643.38 Friday, basically flat on the week, with earnings ahead. That’s probably right. For now, charging-for-all will probably matter more at the margins.","news_type":1},"isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175504514,"gmtCreate":1627039477738,"gmtModify":1703482990049,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175504514","repostId":"1118513308","repostType":2,"repost":{"id":"1118513308","pubTimestamp":1627037228,"share":"https://www.laohu8.com/m/news/1118513308?lang=&edition=full","pubTime":"2021-07-23 18:47","market":"us","language":"en","title":"Tesla puts new Model S deliveries on hold, and it’s unclear why","url":"https://stock-news.laohu8.com/highlight/detail?id=1118513308","media":"Electrek","summary":"Tesla Motors Model S buyers are complaining that they can’t take delivery of their new electric vehi","content":"<p><a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> Model S buyers are complaining that they can’t take delivery of their new electric vehicles as they are told that deliveries are on hold.</p>\n<p>At this point, it’s unclear why.</p>\n<p>After months of delays, Tesla finally&nbsp;started delivering the new version of the Model S&nbsp;last month.</p>\n<p>The new electric sedan comes with a brand-new interior design, a new second-row screen powered by a new gaming computer, and it features a new battery pack and drive units, which enable some insane performance in the Plaid version of the vehicle.</p>\n<p>But now buyers have to wait to experience those new features.</p>\n<p>Several new Tesla Model S buyers have told&nbsp;<i>Electrek</i>&nbsp;and posted to&nbsp;forums&nbsp;about how they are being told by Tesla that there’s a “hold” on delivering the new vehicle.</p>\n<p>Buyers who have been waiting for months for their new vehicles were told that they finally arrived at their local delivery centers, but Tesla wasn’t able to deliver them.</p>\n<p>They are being told a bunch of different excuses for them not being able to complete the delivery, but the common thread appears to be that there’s a “hold” on new Model S.</p>\n<p>Several buyers are being told that the delay is due to “new inspection standards” (viahsien88·on Reddit):</p>\n<p>However, <a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> is not telling them what they are inspecting and why it can’t give a new delivery date.</p>\n<p>Based on buyer reports, the hold appears to be in place since last weekend.</p>\n<p>Some buyers have expressed concerns that it could related to the&nbsp;Tesla Model S Plaid firefrom last month, but there’s no clear evidence of that at the moment.</p>\n<p>CEO Elon Musk has previously commented that one of the reasons for the delay between the launch in January and the start of deliveries in June was to “make sure that the Model S’ new battery pack was safe.”</p>\n<p><b><i>Electrek</i></b><b>‘s take</b></p>\n<p>I would think that if the problem was related to the fire, Tesla would have to do more than put a delivery hold on new deliveries, but also inform current owners.</p>\n<p>It can be anything really.</p>\n<p>In May, we reported on&nbsp;<a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> putting a containment hold on over 10,000 Model 3 and Model Y vehicles. It turned out that it was new vehicles produced without radar and Tesla couldn’t deliver them until it pushed its new “Tesla Vision” software update.</p>\n<p>It could again be software related as some new Model S owners have noted that the new UI developed for the vehicle still needs some refinements.</p>\n<p>We will have to wait and see in order to confirm the actual problem.</p>","source":"lsy1627037122897","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla puts new Model S deliveries on hold, and it’s unclear why</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla puts new Model S deliveries on hold, and it’s unclear why\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 18:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://electrek.co/2021/07/23/tesla-puts-new-model-s-deliveries-on-hold/><strong>Electrek</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla Motors Model S buyers are complaining that they can’t take delivery of their new electric vehicles as they are told that deliveries are on hold.\nAt this point, it’s unclear why.\nAfter months of ...</p>\n\n<a href=\"https://electrek.co/2021/07/23/tesla-puts-new-model-s-deliveries-on-hold/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://electrek.co/2021/07/23/tesla-puts-new-model-s-deliveries-on-hold/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118513308","content_text":"Tesla Motors Model S buyers are complaining that they can’t take delivery of their new electric vehicles as they are told that deliveries are on hold.\nAt this point, it’s unclear why.\nAfter months of delays, Tesla finally started delivering the new version of the Model S last month.\nThe new electric sedan comes with a brand-new interior design, a new second-row screen powered by a new gaming computer, and it features a new battery pack and drive units, which enable some insane performance in the Plaid version of the vehicle.\nBut now buyers have to wait to experience those new features.\nSeveral new Tesla Model S buyers have told Electrek and posted to forums about how they are being told by Tesla that there’s a “hold” on delivering the new vehicle.\nBuyers who have been waiting for months for their new vehicles were told that they finally arrived at their local delivery centers, but Tesla wasn’t able to deliver them.\nThey are being told a bunch of different excuses for them not being able to complete the delivery, but the common thread appears to be that there’s a “hold” on new Model S.\nSeveral buyers are being told that the delay is due to “new inspection standards” (viahsien88·on Reddit):\nHowever, Tesla Motors is not telling them what they are inspecting and why it can’t give a new delivery date.\nBased on buyer reports, the hold appears to be in place since last weekend.\nSome buyers have expressed concerns that it could related to the Tesla Model S Plaid firefrom last month, but there’s no clear evidence of that at the moment.\nCEO Elon Musk has previously commented that one of the reasons for the delay between the launch in January and the start of deliveries in June was to “make sure that the Model S’ new battery pack was safe.”\nElectrek‘s take\nI would think that if the problem was related to the fire, Tesla would have to do more than put a delivery hold on new deliveries, but also inform current owners.\nIt can be anything really.\nIn May, we reported on Tesla Motors putting a containment hold on over 10,000 Model 3 and Model Y vehicles. It turned out that it was new vehicles produced without radar and Tesla couldn’t deliver them until it pushed its new “Tesla Vision” software update.\nIt could again be software related as some new Model S owners have noted that the new UI developed for the vehicle still needs some refinements.\nWe will have to wait and see in order to confirm the actual problem.","news_type":1},"isVote":1,"tweetType":1,"viewCount":288,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175506812,"gmtCreate":1627039261436,"gmtModify":1703482986244,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175506812","repostId":"1118513308","repostType":2,"isVote":1,"tweetType":1,"viewCount":121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172414267,"gmtCreate":1626972341759,"gmtModify":1703481744549,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"The most stable stocks","listText":"The most stable stocks","text":"The most stable stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172414267","repostId":"2153679306","repostType":2,"isVote":1,"tweetType":1,"viewCount":295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172414147,"gmtCreate":1626972296689,"gmtModify":1703481742282,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?&nbsp;","listText":"?&nbsp;","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172414147","repostId":"1125518042","repostType":4,"isVote":1,"tweetType":1,"viewCount":80,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172415262,"gmtCreate":1626972186656,"gmtModify":1703481741634,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hello","listText":"Hello","text":"Hello","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172415262","repostId":"1125518042","repostType":4,"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172415054,"gmtCreate":1626972150478,"gmtModify":1703481740342,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172415054","repostId":"2153673800","repostType":4,"repost":{"id":"2153673800","pubTimestamp":1626958140,"share":"https://www.laohu8.com/m/news/2153673800?lang=&edition=full","pubTime":"2021-07-22 20:49","market":"us","language":"en","title":"What You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2153673800","media":"Motley Fool","summary":"It shouldn't impact the healthcare giant very much.","content":"<p>Three months ago, the Food and Drug Administration placed a warning on the label for <b>Johnson &amp; Johnson</b>'s (NYSE:JNJ) COVID-19 vaccine related to potential rare blood clotting issues. Recently, the regulator added another. In this <i>Motley Fool Live</i> video <b>recorded on July 14, 2021</b>, Motley Fool contributors Keith Speights and Brian Orelli discuss what investors should know about this latest FDA warning.</p>\n<p><b>Keith Speights:</b> Let's move on to another company that's in the news with COVID-19. The FDA has added a new warning to Johnson &amp; Johnson's COVID-19 vaccine, and this is related to a very rare neurological disorder. Brian, what's the potential issue here, and does this impact in any way Johnson &amp; Johnson's ability to market its vaccine?</p>\n<p><b>Brian Orelli:</b> The syndrome is called Guillain-Barre syndrome. It's characterized by numbness at the extremities. Most people recover, but it can lead to full-body paralysis. There has been about 100 cases in the 12 million people who have been vaccinated, and about half of those are coming in men 50 or older, so that seems to be the population that might be most susceptible.</p>\n<p>But if I did the math correctly, I think it's 0.0008% chance of getting this syndrome, so I don't think it's really a major issue. I think the warning by the FDA is probably more for doctors to be able to identify, know that it's happening in a very small number of people, and then they can treat it accordingly.</p>\n<p>I think that's probably the main take-home point here is that it's not a major issue, and I don't that it's going to affect sales of Johnson &amp; Johnson's vaccine in any sort of material way.</p>\n<p><b>Speights:</b> I would totally agree with you there, and it's not going to impact Johnson &amp; Johnson from an investing standpoint probably at all. The vaccine is still only a really small percentage of this company's total sales. Johnson &amp; Johnson is a healthcare giant, the biggest healthcare company in the world.</p>\n<p>My concern on this is doesn't have anything to do with Johnson &amp; Johnson actually. My only concern about this is it's just <a href=\"https://laohu8.com/S/AONE.U\">one</a> other thing for the remaining segment of Americans who are reluctant to take a vaccine, it's just one more thing to make them a little worried.</p>\n<p>Even though like you said, this is an extremely rare occurrence, it's one more thing for people who didn't want to take a vaccine in the first place to say, \"Ah yeah, they found something else with one of these vaccines.\"</p>\n<p><b>Orelli:</b> But your risk of dying from COVID is a lot worse than your risk of getting this disease that may just clear up on its own. I think that that's the message that the government has to get through to people that are on the fence and are not wanting to get the vaccine. But I think it's a difficult proposition to make.</p>\n<p><b>Speights:</b> Exactly. Of course, if anyone has ever watched a TV commercial promoting a prescription drug of any kind, you are going to note the announcer is going to -- very hastily, I might add -- read off a long list of potential side effects.</p>\n<p>I don't know that there's a drug or vaccine out there that doesn't have some type of potential side effect. But most of them are rare, and in this case, extremely rare. This isn't a big deal, in general. But again, my concern is there are folks out there who are looking for reasons not to take a vaccine.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-22 20:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/22/what-you-should-know-about-johnson-johnsons-newest/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Three months ago, the Food and Drug Administration placed a warning on the label for Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine related to potential rare blood clotting issues. Recently, the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/22/what-you-should-know-about-johnson-johnsons-newest/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/07/22/what-you-should-know-about-johnson-johnsons-newest/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153673800","content_text":"Three months ago, the Food and Drug Administration placed a warning on the label for Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine related to potential rare blood clotting issues. Recently, the regulator added another. In this Motley Fool Live video recorded on July 14, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss what investors should know about this latest FDA warning.\nKeith Speights: Let's move on to another company that's in the news with COVID-19. The FDA has added a new warning to Johnson & Johnson's COVID-19 vaccine, and this is related to a very rare neurological disorder. Brian, what's the potential issue here, and does this impact in any way Johnson & Johnson's ability to market its vaccine?\nBrian Orelli: The syndrome is called Guillain-Barre syndrome. It's characterized by numbness at the extremities. Most people recover, but it can lead to full-body paralysis. There has been about 100 cases in the 12 million people who have been vaccinated, and about half of those are coming in men 50 or older, so that seems to be the population that might be most susceptible.\nBut if I did the math correctly, I think it's 0.0008% chance of getting this syndrome, so I don't think it's really a major issue. I think the warning by the FDA is probably more for doctors to be able to identify, know that it's happening in a very small number of people, and then they can treat it accordingly.\nI think that's probably the main take-home point here is that it's not a major issue, and I don't that it's going to affect sales of Johnson & Johnson's vaccine in any sort of material way.\nSpeights: I would totally agree with you there, and it's not going to impact Johnson & Johnson from an investing standpoint probably at all. The vaccine is still only a really small percentage of this company's total sales. Johnson & Johnson is a healthcare giant, the biggest healthcare company in the world.\nMy concern on this is doesn't have anything to do with Johnson & Johnson actually. My only concern about this is it's just one other thing for the remaining segment of Americans who are reluctant to take a vaccine, it's just one more thing to make them a little worried.\nEven though like you said, this is an extremely rare occurrence, it's one more thing for people who didn't want to take a vaccine in the first place to say, \"Ah yeah, they found something else with one of these vaccines.\"\nOrelli: But your risk of dying from COVID is a lot worse than your risk of getting this disease that may just clear up on its own. I think that that's the message that the government has to get through to people that are on the fence and are not wanting to get the vaccine. But I think it's a difficult proposition to make.\nSpeights: Exactly. Of course, if anyone has ever watched a TV commercial promoting a prescription drug of any kind, you are going to note the announcer is going to -- very hastily, I might add -- read off a long list of potential side effects.\nI don't know that there's a drug or vaccine out there that doesn't have some type of potential side effect. But most of them are rare, and in this case, extremely rare. This isn't a big deal, in general. But again, my concern is there are folks out there who are looking for reasons not to take a vaccine.","news_type":1},"isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":807741339,"gmtCreate":1628062200921,"gmtModify":1703500492724,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?...","listText":"?...","text":"?...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/807741339","repostId":"1126131791","repostType":4,"isVote":1,"tweetType":1,"viewCount":383,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807740620,"gmtCreate":1628061958860,"gmtModify":1703500488748,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/807740620","repostId":"2156174967","repostType":4,"isVote":1,"tweetType":1,"viewCount":459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807757918,"gmtCreate":1628061799434,"gmtModify":1703500487098,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/807757918","repostId":"2156174967","repostType":4,"repost":{"id":"2156174967","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1628060758,"share":"https://www.laohu8.com/m/news/2156174967?lang=&edition=full","pubTime":"2021-08-04 15:05","market":"hk","language":"en","title":"ByteDance rival Kuaishou to end services of short video app Zynn this month","url":"https://stock-news.laohu8.com/highlight/detail?id=2156174967","media":"Reuters","summary":"BEIJING, Aug 4 (Reuters) - ByteDance rival Kuaishou Technology said on Wednesday it would stop servi","content":"<p>BEIJING, Aug 4 (Reuters) - ByteDance rival Kuaishou Technology said on Wednesday it would stop services of its short video app Zynn on Aug. 20.</p>\n<p>The termination of Zynn is part of its normal operations, and the company's other products for markets outside China will not be affected, Kuaishou said in a statement.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ByteDance rival Kuaishou to end services of short video app Zynn this month</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nByteDance rival Kuaishou to end services of short video app Zynn this month\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-04 15:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, Aug 4 (Reuters) - ByteDance rival Kuaishou Technology said on Wednesday it would stop services of its short video app Zynn on Aug. 20.</p>\n<p>The termination of Zynn is part of its normal operations, and the company's other products for markets outside China will not be affected, Kuaishou said in a statement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"01024":"快手-W"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156174967","content_text":"BEIJING, Aug 4 (Reuters) - ByteDance rival Kuaishou Technology said on Wednesday it would stop services of its short video app Zynn on Aug. 20.\nThe termination of Zynn is part of its normal operations, and the company's other products for markets outside China will not be affected, Kuaishou said in a statement.","news_type":1},"isVote":1,"tweetType":1,"viewCount":426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807740949,"gmtCreate":1628061934381,"gmtModify":1703500488087,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/807740949","repostId":"1126131791","repostType":4,"isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802465066,"gmtCreate":1627797210355,"gmtModify":1703496039172,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802465066","repostId":"1153879814","repostType":4,"isVote":1,"tweetType":1,"viewCount":457,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806057101,"gmtCreate":1627619512503,"gmtModify":1703493512355,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/806057101","repostId":"1158304787","repostType":4,"repost":{"id":"1158304787","pubTimestamp":1627615747,"share":"https://www.laohu8.com/m/news/1158304787?lang=&edition=full","pubTime":"2021-07-30 11:29","market":"other","language":"en","title":"Oil falls but heads for strong weekly gain on demand growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1158304787","media":"FOX Business","summary":"Both benchmark contracts were headed for gains of around 2% for the week.\nOil pricesfell on Friday b","content":"<p><i><b>Both benchmark contracts were headed for gains of around 2% for the week.</b></i></p>\n<p>Oil pricesfell on Friday but were on track to post solid gains for the week with demand growing faster than supply, while vaccinations dampen the impact of a resurgence incoronaviruscases worldwide.</p>\n<p>Brent crude futures fell 40 cents, or 0.5%, to $75.65 a barrel by 0151 GMT, following a 1.75% jump on Thursday. U.S. West Texas Intermediate (WTI) crude futures fell 38 cents, or 0.5%, to $73.24 a barrel, whittling down a 1.7% rise from Thursday.</p>\n<p>Both benchmark contracts were headed for gains of around 2% for the week, buoyed by indications of tight crude supplies and strong demand in the United States, the world's biggest oil consumer.</p>\n<p>\"We've got stronger prices for a bit longer now, because it's a fundamental supply-demand issue in terms of the recovery in demand we're seeing in places like the United States,\" said Justin Smirk, senior economist at Westpac.</p>\n<p>U.S. crude and gasoline inventories fell sharply in the latest week, with crude stocks at Cushing at their lowest since January 2020, reflecting strong demand growth. ANZ analysts noted even jet fuel consumption in the country had hit its highest level since March 2020.</p>\n<p>Even with coronavirus cases rising in the United States, all around Asia and parts of Europe, analysts said rising vaccination rates would limit the need for the harsh lockdowns that gutted demand during the peak of the pandemic last year.</p>\n<p>\"I think the risks of the large shutdowns we saw last year are much lower,\" Smirk said.</p>\n<p>Analysts point to a rapid rebound in India's gasoline consumption and industrial production following its COVID-19 surge earlier this year as a sign that economies are more resilient to the pandemic.</p>\n<p>\"Yes, Delta is a risk, but is it going to derail demand growth in the second half? We may not see that,\" said Commonwealth Bank commodities analyst Vivek Dhar.</p>\n<ul></ul>","source":"lsy1602566126337","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oil falls but heads for strong weekly gain on demand growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOil falls but heads for strong weekly gain on demand growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-30 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.foxbusiness.com/markets/oil-falls-but-heads-for-strong-weekly-gain-on-demand-growth><strong>FOX Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Both benchmark contracts were headed for gains of around 2% for the week.\nOil pricesfell on Friday but were on track to post solid gains for the week with demand growing faster than supply, while ...</p>\n\n<a href=\"https://www.foxbusiness.com/markets/oil-falls-but-heads-for-strong-weekly-gain-on-demand-growth\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.foxbusiness.com/markets/oil-falls-but-heads-for-strong-weekly-gain-on-demand-growth","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158304787","content_text":"Both benchmark contracts were headed for gains of around 2% for the week.\nOil pricesfell on Friday but were on track to post solid gains for the week with demand growing faster than supply, while vaccinations dampen the impact of a resurgence incoronaviruscases worldwide.\nBrent crude futures fell 40 cents, or 0.5%, to $75.65 a barrel by 0151 GMT, following a 1.75% jump on Thursday. U.S. West Texas Intermediate (WTI) crude futures fell 38 cents, or 0.5%, to $73.24 a barrel, whittling down a 1.7% rise from Thursday.\nBoth benchmark contracts were headed for gains of around 2% for the week, buoyed by indications of tight crude supplies and strong demand in the United States, the world's biggest oil consumer.\n\"We've got stronger prices for a bit longer now, because it's a fundamental supply-demand issue in terms of the recovery in demand we're seeing in places like the United States,\" said Justin Smirk, senior economist at Westpac.\nU.S. crude and gasoline inventories fell sharply in the latest week, with crude stocks at Cushing at their lowest since January 2020, reflecting strong demand growth. ANZ analysts noted even jet fuel consumption in the country had hit its highest level since March 2020.\nEven with coronavirus cases rising in the United States, all around Asia and parts of Europe, analysts said rising vaccination rates would limit the need for the harsh lockdowns that gutted demand during the peak of the pandemic last year.\n\"I think the risks of the large shutdowns we saw last year are much lower,\" Smirk said.\nAnalysts point to a rapid rebound in India's gasoline consumption and industrial production following its COVID-19 surge earlier this year as a sign that economies are more resilient to the pandemic.\n\"Yes, Delta is a risk, but is it going to derail demand growth in the second half? We may not see that,\" said Commonwealth Bank commodities analyst Vivek Dhar.","news_type":1},"isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818347646,"gmtCreate":1630379526185,"gmtModify":1676530286529,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/818347646","repostId":"1168575044","repostType":4,"repost":{"id":"1168575044","pubTimestamp":1630378727,"share":"https://www.laohu8.com/m/news/1168575044?lang=&edition=full","pubTime":"2021-08-31 10:58","market":"us","language":"en","title":"Warren Buffett turns 91, prepares Berkshire for new, tech-driven economy - CNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=1168575044","media":"seekingalpha","summary":"Warren Buffett isshowing a greater opennessto investments that stray from Berkshire Hathaway's (BRK.","content":"<p>Warren Buffett isshowing a greater opennessto investments that stray from Berkshire Hathaway's (BRK.A,BRK.B) old economy core, adaptingto the increasingly tech-driven economy, CNBC's Yun Li writes on The Oracle's 91st birthday.</p>\n<p>Berkshire's exposure to tech stocks has grown to 45% of its equity portfolio, thanks to its massive stake in Apple that has ballooned to more than $120B since its initial investment five years ago, and Buffett has dipped into IPOs and pre-IPO investments.</p>\n<p>\"The equity portfolio today is more dynamic than it was 10-15 years ago with the Todds at the helm,\" says Cathy Seifert, Berkshire analyst at&nbsp;CFRA&nbsp;Research, referring to Buffett's investment lieutenants Todd Combs and Ted Weschler.</p>\n<p>But die-hard Buffett watchers awaiting the next big acquisition instead have seen Berkshire focused on returning capital to shareholders, Li writes, noting the company bought back $6B of its own stock in Q2, after repurchasing a record $24.7B last year.</p>\n<p>Buffett's $6B bet a year ago on Japan's five largest trading houses hasgained more than 30%, outpacing the Topix index's 21% rise, but has not sparked a groundswell of international followers, as many investors remain sidelined by uncertainty over COVID-19 and the country's political leadership.</p>\n<p>Seeking Alpha contributor C Jessen believes \"we can expect more aggressive deployment Of Berkshire's $144B cash... when Ted and Todd take over the investment portfolio.\"</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett turns 91, prepares Berkshire for new, tech-driven economy - CNBC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett turns 91, prepares Berkshire for new, tech-driven economy - CNBC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-31 10:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3735454-warren-buffett-turns-91-prepares-berkshire-for-new-tech-driven-economy-cnbc><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett isshowing a greater opennessto investments that stray from Berkshire Hathaway's (BRK.A,BRK.B) old economy core, adaptingto the increasingly tech-driven economy, CNBC's Yun Li writes on ...</p>\n\n<a href=\"https://seekingalpha.com/news/3735454-warren-buffett-turns-91-prepares-berkshire-for-new-tech-driven-economy-cnbc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","BRK.B":"伯克希尔B"},"source_url":"https://seekingalpha.com/news/3735454-warren-buffett-turns-91-prepares-berkshire-for-new-tech-driven-economy-cnbc","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1168575044","content_text":"Warren Buffett isshowing a greater opennessto investments that stray from Berkshire Hathaway's (BRK.A,BRK.B) old economy core, adaptingto the increasingly tech-driven economy, CNBC's Yun Li writes on The Oracle's 91st birthday.\nBerkshire's exposure to tech stocks has grown to 45% of its equity portfolio, thanks to its massive stake in Apple that has ballooned to more than $120B since its initial investment five years ago, and Buffett has dipped into IPOs and pre-IPO investments.\n\"The equity portfolio today is more dynamic than it was 10-15 years ago with the Todds at the helm,\" says Cathy Seifert, Berkshire analyst at CFRA Research, referring to Buffett's investment lieutenants Todd Combs and Ted Weschler.\nBut die-hard Buffett watchers awaiting the next big acquisition instead have seen Berkshire focused on returning capital to shareholders, Li writes, noting the company bought back $6B of its own stock in Q2, after repurchasing a record $24.7B last year.\nBuffett's $6B bet a year ago on Japan's five largest trading houses hasgained more than 30%, outpacing the Topix index's 21% rise, but has not sparked a groundswell of international followers, as many investors remain sidelined by uncertainty over COVID-19 and the country's political leadership.\nSeeking Alpha contributor C Jessen believes \"we can expect more aggressive deployment Of Berkshire's $144B cash... when Ted and Todd take over the investment portfolio.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":400,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806057060,"gmtCreate":1627619489750,"gmtModify":1703493512193,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/806057060","repostId":"2155513329","repostType":4,"isVote":1,"tweetType":1,"viewCount":266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174538713,"gmtCreate":1627109272932,"gmtModify":1703484421241,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?....","listText":"?....","text":"?....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/174538713","repostId":"1109439356","repostType":4,"repost":{"id":"1109439356","pubTimestamp":1627096841,"share":"https://www.laohu8.com/m/news/1109439356?lang=&edition=full","pubTime":"2021-07-24 11:20","market":"us","language":"en","title":"Musk Tweets That Tesla Will Share Its Charging Network. Why That’s a Savvy Move.","url":"https://stock-news.laohu8.com/highlight/detail?id=1109439356","media":"Barrons","summary":"This past Wednesday, Elon Musk tweeted that Tesla would open up its global network of 25,000-plus chargers to non-Tesla electric vehicles. That might seem strange, even for Musk. But it could also be savvy. “It’s brilliant,” Gary Black tells Barron’s. Former Wall Street analyst and executive Black has amassed 80,000 Twitter followers for his views on stocks, including Tesla, which he owns shares in. “We like the move,” adds Wedbush analyst Dan Ives, also a Tesla bull. He rates the stock a Buy, w","content":"<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e34edc30ae38ac91a9f953a1dcae4dbc\" tg-width=\"930\" tg-height=\"619\" width=\"100%\" height=\"auto\"><span>Illustration by Elias Stein</span></p>\n<p>This past Wednesday, Elon Musk tweeted that Tesla would open up its global network of 25,000-plus chargers to non-Tesla electric vehicles. That might seem strange, even for Musk. But it could also be savvy. “It’s brilliant,” Gary Black tells Barron’s. Former Wall Street analyst and executive Black has amassed 80,000 Twitter followers for his views on stocks, including Tesla, which he owns shares in. “We like the move,” adds Wedbush analyst Dan Ives, also a Tesla bull. He rates the stock a Buy, with a $1,000 price target. “While some will view it as letting competition in on Tesla’s supercharger moat, we disagree…”</p>\n<p>For all the competition between their makers, EVs account for less than 5% of all new cars sold in the U.S. The larger struggle remains between electric- and gasoline-powered vehicles. Anything Musk does to make buying electrics easier is good for Tesla. Besides, Tesla could make a lot of money by opening its network. Although Tesla didn’t respond to a question about potential pricing, charging won’t be free, and refusing to let others use the system would be like a gas station only servicing Fords. And charging eventually will be as ubiquitous as gas stations.</p>\n<p>Then there’s the free publicity and advertising. Opening up the charging network shows Tesla is interested in overall EV adoption and not just in selling its own vehicles. That’s positive for the brand. And it means that thousands of EV buyers will be pulling up to a Tesla logo, again and again.</p>\n<p>Investors brushed off the tweet. Tesla closed at $643.38 Friday, basically flat on the week, with earnings ahead. That’s probably right. For now, charging-for-all will probably matter more at the margins.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk Tweets That Tesla Will Share Its Charging Network. Why That’s a Savvy Move.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk Tweets That Tesla Will Share Its Charging Network. Why That’s a Savvy Move.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-24 11:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/elon-musk-tesla-charging-network-51627090559><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Illustration by Elias Stein\nThis past Wednesday, Elon Musk tweeted that Tesla would open up its global network of 25,000-plus chargers to non-Tesla electric vehicles. That might seem strange, even for...</p>\n\n<a href=\"https://www.barrons.com/articles/elon-musk-tesla-charging-network-51627090559\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/elon-musk-tesla-charging-network-51627090559","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109439356","content_text":"Illustration by Elias Stein\nThis past Wednesday, Elon Musk tweeted that Tesla would open up its global network of 25,000-plus chargers to non-Tesla electric vehicles. That might seem strange, even for Musk. But it could also be savvy. “It’s brilliant,” Gary Black tells Barron’s. Former Wall Street analyst and executive Black has amassed 80,000 Twitter followers for his views on stocks, including Tesla, which he owns shares in. “We like the move,” adds Wedbush analyst Dan Ives, also a Tesla bull. He rates the stock a Buy, with a $1,000 price target. “While some will view it as letting competition in on Tesla’s supercharger moat, we disagree…”\nFor all the competition between their makers, EVs account for less than 5% of all new cars sold in the U.S. The larger struggle remains between electric- and gasoline-powered vehicles. Anything Musk does to make buying electrics easier is good for Tesla. Besides, Tesla could make a lot of money by opening its network. Although Tesla didn’t respond to a question about potential pricing, charging won’t be free, and refusing to let others use the system would be like a gas station only servicing Fords. And charging eventually will be as ubiquitous as gas stations.\nThen there’s the free publicity and advertising. Opening up the charging network shows Tesla is interested in overall EV adoption and not just in selling its own vehicles. That’s positive for the brand. And it means that thousands of EV buyers will be pulling up to a Tesla logo, again and again.\nInvestors brushed off the tweet. Tesla closed at $643.38 Friday, basically flat on the week, with earnings ahead. That’s probably right. For now, charging-for-all will probably matter more at the margins.","news_type":1},"isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175504514,"gmtCreate":1627039477738,"gmtModify":1703482990049,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175504514","repostId":"1118513308","repostType":2,"isVote":1,"tweetType":1,"viewCount":288,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175506812,"gmtCreate":1627039261436,"gmtModify":1703482986244,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175506812","repostId":"1118513308","repostType":2,"isVote":1,"tweetType":1,"viewCount":121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802399728,"gmtCreate":1627714584864,"gmtModify":1703495141438,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802399728","repostId":"1138566016","repostType":4,"repost":{"id":"1138566016","pubTimestamp":1627689251,"share":"https://www.laohu8.com/m/news/1138566016?lang=&edition=full","pubTime":"2021-07-31 07:54","market":"us","language":"en","title":"It’s Open Season on Closed-End Fund Activists. How Fund Holders Can Win—and Lose","url":"https://stock-news.laohu8.com/highlight/detail?id=1138566016","media":"Barron's","summary":"TheTempleton Global Incomefund frustrated investors for years. Despite star manager Michael Hasensta","content":"<p>TheTempleton Global Incomefund frustrated investors for years. Despite star manager Michael Hasenstab at the helm, the closed-end fund returned an average of 0.3% annually in the past decade, versus an average 7% for peers in global income. Also frustrating, its shares rarely traded close to the fund’s underlying net asset value, or NAV. The discount averaged 11% in the past three years.</p>\n<p>Investors have caught a break, however, thanks to Saba Capital Management, a hedge fund shop run by activist investor Boaz Weinstein. Saba amassed a 20% stake in the Templeton fund and recently won four contested board seats. It has been pressuring the board to take actions to boost the share price. Its moves have paid off: The fund has returned a total 4.5% this year as its share price improved, and the discount to NAV has shrunk to 4%.</p>\n<p>Tactics like Saba’s have long infuriated mutual fund companies; no one wants a hedge fund threatening a coup. Now, with some help from Congress, the playing field could tilt in favor of closed-end funds and their company sponsors, due to a bill recently introduced in the House. That could work against the interests of fund investors.</p>\n<p>The Increasing Investor Opportunities Act, introduced in June by Rep. Anthony Gonzalez (R., Ohio) and Rep. Gregory Meeks (D., New York), includes two measures that could make it much tougher for hedge funds to pressure closed-end funds and win proxy fights. One proposed change would lift the current 15% limit on closed-end-fund ownership of illiquid private funds, such as venture-capital and private-equity funds. A second measure would prevent activist hedge funds from acquiring more than 10% of a closed-end fund’s shares.</p>\n<p>A spokesman for Gonzalez declined to comment. Meeks didn’t respond to requests for comment.</p>\n<p>Proponents of the changes say they would expand access to private markets for retail investors. They also say hedge funds are exploiting gaps in securities laws at a cost to long-term shareholders, saddling them with tax liabilities, higher fees, and forced fund liquidations. The bill would eliminate a “loophole that activist investors have used to extract short-term profits at the expense of retail investors,” the Investment Company Institute, or ICI, said in a recent statement.</p>\n<p>Hedge funds and portfolio managers who invest in closed-end funds say that mutual fund companies are simply trying to protect a pool of assets and fees from shareholder interference. Most retail investors don’t vote their shares in proxy contests. That may leave fund boards largely free to pursue their own agendas.</p>\n<p>“Activism plays an important role, and if this bill passes, it will become more difficult for activists to threaten or create changes,” says Matt Buffington, a portfolio manager at Dryden Capital, an activist hedge fund.</p>\n<p>Gregory Neer, a portfolio manager with Relative Value Partners, an advisory firm that invests in closed-end funds, agrees. “The ability for investors to pressure funds is beneficial to all shareholders,” he says.</p>\n<p>Closed-end funds have long been popular with investors due to their high yields and steady distributions. Many use leverage, borrowing money at market rates to boost payouts. They also generate income with options strategies and investments in high-yielding areas of the stock and bond markets.</p>\n<p>But the funds have structural drawbacks. Expense ratios are steep, averaging 2.1%, according to Morningstar Direct. And since the funds have a fixed number of shares outstanding, prices reflect market demand for both a fund and its underlying assets. Funds usually trade at a discount to NAV. While it is attractive, in theory, to pay 90 cents for a dollar of assets, investors might never see the extra dime.</p>\n<p>Hedge funds aim to exploit this inefficiency, buying closed-end funds at below-market value. They then pressure fund boards to take steps to lift the funds’ prices. The playbook is straightforward: accumulate a stake, win board seats, and then force a fund company into a tender offer, whereby it agrees to repurchase shares at nearly full price.</p>\n<p>If that fails, a hedge fund might try to replace a fund’s manager, orchestrate a liquidation of the fund, or get it converted to an open-end fund—moves that could also pay off with the share price rising to parity with the NAV. Firms like Saba have also taken over funds entirely.</p>\n<p>Giving closed-end funds freedom to own more private securities could throw a wrench into the strategy. Tender offers work only if a fund can liquidate most of its holdings at market prices. Because venture-capital and private-equity holdings generally don’t trade publicly, their pricing isn’t transparent. “When closed-end funds invest in illiquid things, it protects them from activism,” one activist manager tells<i>Barron’s</i>.</p>\n<p>Removing the cap on private-fund ownership is “in line with a legislative agenda of getting retail investors more access to private investments,” says Thomas DeCapo, an attorney for the mutual fund industry.</p>\n<p>And capping activists at 10% of a fund doesn’t stop them from mounting proxy campaigns. “Nothing about this is antidemocratic,” he says. “It doesn’t stop a majority of investors who are unhappy or want change. It stops one investor from using its economic power, with other people’s money, to basically force changes on everybody else.”</p>\n<p>Investor advocates see it differently, however, saying fund investors could wind up paying higher fees for funds that hold more-opaque investments. “It’s just another fund-of-funds structure, and those are notoriously high-fee,” says Tyler Gellasch, head of Healthy Markets, an investor-protection group.</p>\n<p>Individual hedge funds technically can’t own more than 3% of a closed-end fund, under ownership restrictions in the Investment Company Act of 1940. But they skirt the rule by building stakes through affiliated entities, creating enough of a critical mass to force changes at a fund through proxy voting.</p>\n<p>The ICI—the mutual fund industry’s lobby—has tried to persuade regulators to crack down on hedge funds. In a submission to the Securities and Exchange Commission last year, the ICI argued that hedge fund campaigns often consume a fund’s resources, trigger tax liabilities for long-term investors, and result in the forced selling of securities to meet a hedge fund’s demands for a tender offer. A fund’s expense ratio could increase if it is forced to buy back shares and its asset base shrinks.</p>\n<p>The activist community’s “assault” on the industry has had a chilling effect on product launches, the ICI said, resulting in fewer closed-end funds on the market today than in 2007.</p>\n<p>But hedge funds argue that changing the 1940 act would amount to a power grab by mutual funds. “This is all coming from the mutual fund industry, and it’s no coincidence that this protects them,” says Phil Goldstein, co-founder of Bulldog Investors, an activist that has long targeted closed-end funds. “There are funds with terrible performance and wide discounts. The ICI never says we need a mechanism where shareholders can hold those managers accountable.”</p>\n<p>Imposing an ownership cap would also make proxy campaigns less economic. Limited to 10%, hedge funds wouldn’t own enough shares, with sufficient economic interest, to justify the expense of a proxy contest, which can cost millions of dollars. “If you’re limited to 10% and have to spend 2.5% of your assets on a proxy campaign, you’d say it’s too risky,” says Goldstein. “Meanwhile, management isn’t spending anything—just shareholder money. They want to make it economically unattractive to run a proxy contest.”</p>\n<p>Regulators and courts have expressed skepticism about some defenses that closed-end funds have adopted to prevent shareholder challenges. And, the SEC might not side with the fund industry. Since 2010, the SEC has warned fund companies against using state securities laws to thwart hedge fund takeovers. The SEC dropped its objection to these state “control share” laws last year under its Republican chairman, Jay Clayton. But the new, Democratic chairman, Gary Gensler, might reinstate the SEC’s objection—a reason for the industry to enlist Congress to change the law. The SEC didn’t respond to requests for comment.</p>\n<p>Institutional Shareholder Services,a firm that makes recommendations on proxy voting, says investors should reject fund companies’ use of state control-share laws, which limit the voting rights of shareholders. With the SEC on the sidelines, ISS says, “CEF shareholders are denied important voting rights and are subject to management entrenchment.”</p>\n<p><img src=\"https://static.tigerbbs.com/70323ed9daef142f19afd48be72b6299\" tg-width=\"755\" tg-height=\"334\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/68beb47d59eb02e90b04eb7093f9f17b\" tg-width=\"759\" tg-height=\"285\" referrerpolicy=\"no-referrer\">Hedge funds don’t always win, but investors might want to ride along as activists build a stake. “When an activist comes in, you usually see an increase in the share price and a decrease in the discount,” says Matt Souther, an associate finance professor at the University of South Carolina.</p>\n<p>Templeton Global Income’s (ticker: GIM) discount to NAV could narrow further if Saba acquires more shares or tries to take over the fund’s $743 million in assets. Saba recently took over management of another fund, Voya Prime Rate Trust, which it rebrandedSaba Capital Income &amp; Opportunities(BRW).Franklin Templetonand Saba declined to comment.</p>\n<p>Miller/Howard High Income Equity(HIE) is also in Saba’s crosshairs. The fund is a “term trust” with a mandated liquidation date in 2024. It trades at a 5.9% discount to NAV. “In a worst-case scenario, you buy it at a discount and you’ll earn an excess return from now to 2024 because that discount will narrow,” says Patrick Galley, co-manager ofRiverNorth Opportunities(RIV), a closed-end fund that owns HIE.</p>\n<p>Other closed-end funds in which Saba owns stakes includeSource Capital(SOR) andInvesco Dynamic Credit Opportunities(VTA). Bulldog has built a position inTortoise Energy Independence(NDP).</p>\n<p>Some closed-end funds look attractive on their fundamentals.Adams Diversified Equity(ADX) offers exposure to big tech stocks, trades at a 14% discount to NAV, and is committed to an annualized distribution of at least 6%. “For investors who expect tech to do well, ADX is a good holding,” says David Tepper, a closed-end investor and head of Tepper Capital Management in San Francisco.</p>\n<p>Sprott Focus Trust(FUND) is another fund he likes. Veteran small-cap manager Whitney George runs it, and his family owns 45% of the shares. It trades at a 10% discount and yields 5.7%. Tepper also favorsRoyce Global Value Trust(RGT), trading at a 9% discount and yielding 7.9%.</p>\n<p>None of these funds has attracted much activist involvement, according to securities filings. But if activists see opportunity, they could pile in and pressure fund management—assuming that Congress doesn’t rewrite the rules of engagement.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>It’s Open Season on Closed-End Fund Activists. How Fund Holders Can Win—and Lose</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIt’s Open Season on Closed-End Fund Activists. How Fund Holders Can Win—and Lose\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-31 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/congress-closed-end-funds-legislation-51627657959?mod=newsviewer_click><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TheTempleton Global Incomefund frustrated investors for years. Despite star manager Michael Hasenstab at the helm, the closed-end fund returned an average of 0.3% annually in the past decade, versus ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/congress-closed-end-funds-legislation-51627657959?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/articles/congress-closed-end-funds-legislation-51627657959?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138566016","content_text":"TheTempleton Global Incomefund frustrated investors for years. Despite star manager Michael Hasenstab at the helm, the closed-end fund returned an average of 0.3% annually in the past decade, versus an average 7% for peers in global income. Also frustrating, its shares rarely traded close to the fund’s underlying net asset value, or NAV. The discount averaged 11% in the past three years.\nInvestors have caught a break, however, thanks to Saba Capital Management, a hedge fund shop run by activist investor Boaz Weinstein. Saba amassed a 20% stake in the Templeton fund and recently won four contested board seats. It has been pressuring the board to take actions to boost the share price. Its moves have paid off: The fund has returned a total 4.5% this year as its share price improved, and the discount to NAV has shrunk to 4%.\nTactics like Saba’s have long infuriated mutual fund companies; no one wants a hedge fund threatening a coup. Now, with some help from Congress, the playing field could tilt in favor of closed-end funds and their company sponsors, due to a bill recently introduced in the House. That could work against the interests of fund investors.\nThe Increasing Investor Opportunities Act, introduced in June by Rep. Anthony Gonzalez (R., Ohio) and Rep. Gregory Meeks (D., New York), includes two measures that could make it much tougher for hedge funds to pressure closed-end funds and win proxy fights. One proposed change would lift the current 15% limit on closed-end-fund ownership of illiquid private funds, such as venture-capital and private-equity funds. A second measure would prevent activist hedge funds from acquiring more than 10% of a closed-end fund’s shares.\nA spokesman for Gonzalez declined to comment. Meeks didn’t respond to requests for comment.\nProponents of the changes say they would expand access to private markets for retail investors. They also say hedge funds are exploiting gaps in securities laws at a cost to long-term shareholders, saddling them with tax liabilities, higher fees, and forced fund liquidations. The bill would eliminate a “loophole that activist investors have used to extract short-term profits at the expense of retail investors,” the Investment Company Institute, or ICI, said in a recent statement.\nHedge funds and portfolio managers who invest in closed-end funds say that mutual fund companies are simply trying to protect a pool of assets and fees from shareholder interference. Most retail investors don’t vote their shares in proxy contests. That may leave fund boards largely free to pursue their own agendas.\n“Activism plays an important role, and if this bill passes, it will become more difficult for activists to threaten or create changes,” says Matt Buffington, a portfolio manager at Dryden Capital, an activist hedge fund.\nGregory Neer, a portfolio manager with Relative Value Partners, an advisory firm that invests in closed-end funds, agrees. “The ability for investors to pressure funds is beneficial to all shareholders,” he says.\nClosed-end funds have long been popular with investors due to their high yields and steady distributions. Many use leverage, borrowing money at market rates to boost payouts. They also generate income with options strategies and investments in high-yielding areas of the stock and bond markets.\nBut the funds have structural drawbacks. Expense ratios are steep, averaging 2.1%, according to Morningstar Direct. And since the funds have a fixed number of shares outstanding, prices reflect market demand for both a fund and its underlying assets. Funds usually trade at a discount to NAV. While it is attractive, in theory, to pay 90 cents for a dollar of assets, investors might never see the extra dime.\nHedge funds aim to exploit this inefficiency, buying closed-end funds at below-market value. They then pressure fund boards to take steps to lift the funds’ prices. The playbook is straightforward: accumulate a stake, win board seats, and then force a fund company into a tender offer, whereby it agrees to repurchase shares at nearly full price.\nIf that fails, a hedge fund might try to replace a fund’s manager, orchestrate a liquidation of the fund, or get it converted to an open-end fund—moves that could also pay off with the share price rising to parity with the NAV. Firms like Saba have also taken over funds entirely.\nGiving closed-end funds freedom to own more private securities could throw a wrench into the strategy. Tender offers work only if a fund can liquidate most of its holdings at market prices. Because venture-capital and private-equity holdings generally don’t trade publicly, their pricing isn’t transparent. “When closed-end funds invest in illiquid things, it protects them from activism,” one activist manager tellsBarron’s.\nRemoving the cap on private-fund ownership is “in line with a legislative agenda of getting retail investors more access to private investments,” says Thomas DeCapo, an attorney for the mutual fund industry.\nAnd capping activists at 10% of a fund doesn’t stop them from mounting proxy campaigns. “Nothing about this is antidemocratic,” he says. “It doesn’t stop a majority of investors who are unhappy or want change. It stops one investor from using its economic power, with other people’s money, to basically force changes on everybody else.”\nInvestor advocates see it differently, however, saying fund investors could wind up paying higher fees for funds that hold more-opaque investments. “It’s just another fund-of-funds structure, and those are notoriously high-fee,” says Tyler Gellasch, head of Healthy Markets, an investor-protection group.\nIndividual hedge funds technically can’t own more than 3% of a closed-end fund, under ownership restrictions in the Investment Company Act of 1940. But they skirt the rule by building stakes through affiliated entities, creating enough of a critical mass to force changes at a fund through proxy voting.\nThe ICI—the mutual fund industry’s lobby—has tried to persuade regulators to crack down on hedge funds. In a submission to the Securities and Exchange Commission last year, the ICI argued that hedge fund campaigns often consume a fund’s resources, trigger tax liabilities for long-term investors, and result in the forced selling of securities to meet a hedge fund’s demands for a tender offer. A fund’s expense ratio could increase if it is forced to buy back shares and its asset base shrinks.\nThe activist community’s “assault” on the industry has had a chilling effect on product launches, the ICI said, resulting in fewer closed-end funds on the market today than in 2007.\nBut hedge funds argue that changing the 1940 act would amount to a power grab by mutual funds. “This is all coming from the mutual fund industry, and it’s no coincidence that this protects them,” says Phil Goldstein, co-founder of Bulldog Investors, an activist that has long targeted closed-end funds. “There are funds with terrible performance and wide discounts. The ICI never says we need a mechanism where shareholders can hold those managers accountable.”\nImposing an ownership cap would also make proxy campaigns less economic. Limited to 10%, hedge funds wouldn’t own enough shares, with sufficient economic interest, to justify the expense of a proxy contest, which can cost millions of dollars. “If you’re limited to 10% and have to spend 2.5% of your assets on a proxy campaign, you’d say it’s too risky,” says Goldstein. “Meanwhile, management isn’t spending anything—just shareholder money. They want to make it economically unattractive to run a proxy contest.”\nRegulators and courts have expressed skepticism about some defenses that closed-end funds have adopted to prevent shareholder challenges. And, the SEC might not side with the fund industry. Since 2010, the SEC has warned fund companies against using state securities laws to thwart hedge fund takeovers. The SEC dropped its objection to these state “control share” laws last year under its Republican chairman, Jay Clayton. But the new, Democratic chairman, Gary Gensler, might reinstate the SEC’s objection—a reason for the industry to enlist Congress to change the law. The SEC didn’t respond to requests for comment.\nInstitutional Shareholder Services,a firm that makes recommendations on proxy voting, says investors should reject fund companies’ use of state control-share laws, which limit the voting rights of shareholders. With the SEC on the sidelines, ISS says, “CEF shareholders are denied important voting rights and are subject to management entrenchment.”\nHedge funds don’t always win, but investors might want to ride along as activists build a stake. “When an activist comes in, you usually see an increase in the share price and a decrease in the discount,” says Matt Souther, an associate finance professor at the University of South Carolina.\nTempleton Global Income’s (ticker: GIM) discount to NAV could narrow further if Saba acquires more shares or tries to take over the fund’s $743 million in assets. Saba recently took over management of another fund, Voya Prime Rate Trust, which it rebrandedSaba Capital Income & Opportunities(BRW).Franklin Templetonand Saba declined to comment.\nMiller/Howard High Income Equity(HIE) is also in Saba’s crosshairs. The fund is a “term trust” with a mandated liquidation date in 2024. It trades at a 5.9% discount to NAV. “In a worst-case scenario, you buy it at a discount and you’ll earn an excess return from now to 2024 because that discount will narrow,” says Patrick Galley, co-manager ofRiverNorth Opportunities(RIV), a closed-end fund that owns HIE.\nOther closed-end funds in which Saba owns stakes includeSource Capital(SOR) andInvesco Dynamic Credit Opportunities(VTA). Bulldog has built a position inTortoise Energy Independence(NDP).\nSome closed-end funds look attractive on their fundamentals.Adams Diversified Equity(ADX) offers exposure to big tech stocks, trades at a 14% discount to NAV, and is committed to an annualized distribution of at least 6%. “For investors who expect tech to do well, ADX is a good holding,” says David Tepper, a closed-end investor and head of Tepper Capital Management in San Francisco.\nSprott Focus Trust(FUND) is another fund he likes. Veteran small-cap manager Whitney George runs it, and his family owns 45% of the shares. It trades at a 10% discount and yields 5.7%. Tepper also favorsRoyce Global Value Trust(RGT), trading at a 9% discount and yielding 7.9%.\nNone of these funds has attracted much activist involvement, according to securities filings. But if activists see opportunity, they could pile in and pressure fund management—assuming that Congress doesn’t rewrite the rules of engagement.","news_type":1},"isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802393985,"gmtCreate":1627714611747,"gmtModify":1703495141112,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"//<a href=\"https://laohu8.com/U/4087121361671570\">@imOxy</a>: ??","listText":"//<a href=\"https://laohu8.com/U/4087121361671570\">@imOxy</a>: ??","text":"//@imOxy: ??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802393985","repostId":"1138566016","repostType":4,"isVote":1,"tweetType":1,"viewCount":436,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174536148,"gmtCreate":1627109311584,"gmtModify":1703484422853,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/174536148","repostId":"2153933012","repostType":2,"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172414267,"gmtCreate":1626972341759,"gmtModify":1703481744549,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"The most stable stocks","listText":"The most stable stocks","text":"The most stable stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172414267","repostId":"2153679306","repostType":2,"isVote":1,"tweetType":1,"viewCount":295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172414147,"gmtCreate":1626972296689,"gmtModify":1703481742282,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"?&nbsp;","listText":"?&nbsp;","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172414147","repostId":"1125518042","repostType":4,"repost":{"id":"1125518042","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626957784,"share":"https://www.laohu8.com/m/news/1125518042?lang=&edition=full","pubTime":"2021-07-22 20:43","market":"us","language":"en","title":"Biogen pushes back against critics of Alzheimer's drug as early sales hit $2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1125518042","media":"Reuters","summary":"(Reuters) -Biogen Inc on Thursday mounted a defense of its interactions with U.S. regulators that le","content":"<p>(Reuters) -<a href=\"https://laohu8.com/S/BIIB\">Biogen</a> Inc on Thursday mounted a defense of its interactions with U.S. regulators that led to a controversial approval of its new Alzheimer’s treatment, as the company seeks to quell concerns about the drug’s effectiveness.</p>\n<p>The company recorded nearly $2 million in sales of the drug, which was approved on June 7, in the second quarter, while analysts on average had estimated $3.23 million, according to IBES data from Refinitiv.</p>\n<p>The decision by the U.S. Food and Drug Administration to approve Aduhelm despite its panel of outside experts recommending against it has drawn criticism, with the agency asking federal investigators to review the process.</p>\n<p>“We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab. A better understanding of the facts is good for everyone involved,” Alfred Sandrock, head of research and development at Biogen, said in an open letter to the Alzheimer’s disease community.</p>\n<p>The company’s comments about the drug’s approval make it clear that there is “little chance of the controversy abating in the near term,” said Wedbush analyst Laura Chico.</p>\n<p>Aduhelm’s $56,000 per year price tag has also spurred lawmakers to launch a probe, with insurers waiting for clarity before starting coverage.</p>\n<p>The drugmaker expects modest revenue from Aduhelm this year and to ramp up thereafter, adding it was seeing “strong indications of very high initial patient interest as well as increased referrals.”</p>\n<p>Biogen now expects total sales of $10.65 billion to $10.85 billion this year, compared with its prior estimate of $10.45 billion to $10.75 billion.</p>\n<p>The company’s shares gained 1.1% to $326.50 in early trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen pushes back against critics of Alzheimer's drug as early sales hit $2 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen pushes back against critics of Alzheimer's drug as early sales hit $2 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-22 20:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Reuters) -<a href=\"https://laohu8.com/S/BIIB\">Biogen</a> Inc on Thursday mounted a defense of its interactions with U.S. regulators that led to a controversial approval of its new Alzheimer’s treatment, as the company seeks to quell concerns about the drug’s effectiveness.</p>\n<p>The company recorded nearly $2 million in sales of the drug, which was approved on June 7, in the second quarter, while analysts on average had estimated $3.23 million, according to IBES data from Refinitiv.</p>\n<p>The decision by the U.S. Food and Drug Administration to approve Aduhelm despite its panel of outside experts recommending against it has drawn criticism, with the agency asking federal investigators to review the process.</p>\n<p>“We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab. A better understanding of the facts is good for everyone involved,” Alfred Sandrock, head of research and development at Biogen, said in an open letter to the Alzheimer’s disease community.</p>\n<p>The company’s comments about the drug’s approval make it clear that there is “little chance of the controversy abating in the near term,” said Wedbush analyst Laura Chico.</p>\n<p>Aduhelm’s $56,000 per year price tag has also spurred lawmakers to launch a probe, with insurers waiting for clarity before starting coverage.</p>\n<p>The drugmaker expects modest revenue from Aduhelm this year and to ramp up thereafter, adding it was seeing “strong indications of very high initial patient interest as well as increased referrals.”</p>\n<p>Biogen now expects total sales of $10.65 billion to $10.85 billion this year, compared with its prior estimate of $10.45 billion to $10.75 billion.</p>\n<p>The company’s shares gained 1.1% to $326.50 in early trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125518042","content_text":"(Reuters) -Biogen Inc on Thursday mounted a defense of its interactions with U.S. regulators that led to a controversial approval of its new Alzheimer’s treatment, as the company seeks to quell concerns about the drug’s effectiveness.\nThe company recorded nearly $2 million in sales of the drug, which was approved on June 7, in the second quarter, while analysts on average had estimated $3.23 million, according to IBES data from Refinitiv.\nThe decision by the U.S. Food and Drug Administration to approve Aduhelm despite its panel of outside experts recommending against it has drawn criticism, with the agency asking federal investigators to review the process.\n“We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab. A better understanding of the facts is good for everyone involved,” Alfred Sandrock, head of research and development at Biogen, said in an open letter to the Alzheimer’s disease community.\nThe company’s comments about the drug’s approval make it clear that there is “little chance of the controversy abating in the near term,” said Wedbush analyst Laura Chico.\nAduhelm’s $56,000 per year price tag has also spurred lawmakers to launch a probe, with insurers waiting for clarity before starting coverage.\nThe drugmaker expects modest revenue from Aduhelm this year and to ramp up thereafter, adding it was seeing “strong indications of very high initial patient interest as well as increased referrals.”\nBiogen now expects total sales of $10.65 billion to $10.85 billion this year, compared with its prior estimate of $10.45 billion to $10.75 billion.\nThe company’s shares gained 1.1% to $326.50 in early trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":80,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172415262,"gmtCreate":1626972186656,"gmtModify":1703481741634,"author":{"id":"4087121361671570","authorId":"4087121361671570","name":"imOxy","avatar":"https://static.tigerbbs.com/9f451ff28c6a6373be19694c5de4a14f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hello","listText":"Hello","text":"Hello","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172415262","repostId":"1125518042","repostType":4,"repost":{"id":"1125518042","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626957784,"share":"https://www.laohu8.com/m/news/1125518042?lang=&edition=full","pubTime":"2021-07-22 20:43","market":"us","language":"en","title":"Biogen pushes back against critics of Alzheimer's drug as early sales hit $2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1125518042","media":"Reuters","summary":"(Reuters) -Biogen Inc on Thursday mounted a defense of its interactions with U.S. regulators that le","content":"<p>(Reuters) -<a href=\"https://laohu8.com/S/BIIB\">Biogen</a> Inc on Thursday mounted a defense of its interactions with U.S. regulators that led to a controversial approval of its new Alzheimer’s treatment, as the company seeks to quell concerns about the drug’s effectiveness.</p>\n<p>The company recorded nearly $2 million in sales of the drug, which was approved on June 7, in the second quarter, while analysts on average had estimated $3.23 million, according to IBES data from Refinitiv.</p>\n<p>The decision by the U.S. Food and Drug Administration to approve Aduhelm despite its panel of outside experts recommending against it has drawn criticism, with the agency asking federal investigators to review the process.</p>\n<p>“We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab. A better understanding of the facts is good for everyone involved,” Alfred Sandrock, head of research and development at Biogen, said in an open letter to the Alzheimer’s disease community.</p>\n<p>The company’s comments about the drug’s approval make it clear that there is “little chance of the controversy abating in the near term,” said Wedbush analyst Laura Chico.</p>\n<p>Aduhelm’s $56,000 per year price tag has also spurred lawmakers to launch a probe, with insurers waiting for clarity before starting coverage.</p>\n<p>The drugmaker expects modest revenue from Aduhelm this year and to ramp up thereafter, adding it was seeing “strong indications of very high initial patient interest as well as increased referrals.”</p>\n<p>Biogen now expects total sales of $10.65 billion to $10.85 billion this year, compared with its prior estimate of $10.45 billion to $10.75 billion.</p>\n<p>The company’s shares gained 1.1% to $326.50 in early trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen pushes back against critics of Alzheimer's drug as early sales hit $2 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen pushes back against critics of Alzheimer's drug as early sales hit $2 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-22 20:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Reuters) -<a href=\"https://laohu8.com/S/BIIB\">Biogen</a> Inc on Thursday mounted a defense of its interactions with U.S. regulators that led to a controversial approval of its new Alzheimer’s treatment, as the company seeks to quell concerns about the drug’s effectiveness.</p>\n<p>The company recorded nearly $2 million in sales of the drug, which was approved on June 7, in the second quarter, while analysts on average had estimated $3.23 million, according to IBES data from Refinitiv.</p>\n<p>The decision by the U.S. Food and Drug Administration to approve Aduhelm despite its panel of outside experts recommending against it has drawn criticism, with the agency asking federal investigators to review the process.</p>\n<p>“We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab. A better understanding of the facts is good for everyone involved,” Alfred Sandrock, head of research and development at Biogen, said in an open letter to the Alzheimer’s disease community.</p>\n<p>The company’s comments about the drug’s approval make it clear that there is “little chance of the controversy abating in the near term,” said Wedbush analyst Laura Chico.</p>\n<p>Aduhelm’s $56,000 per year price tag has also spurred lawmakers to launch a probe, with insurers waiting for clarity before starting coverage.</p>\n<p>The drugmaker expects modest revenue from Aduhelm this year and to ramp up thereafter, adding it was seeing “strong indications of very high initial patient interest as well as increased referrals.”</p>\n<p>Biogen now expects total sales of $10.65 billion to $10.85 billion this year, compared with its prior estimate of $10.45 billion to $10.75 billion.</p>\n<p>The company’s shares gained 1.1% to $326.50 in early trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125518042","content_text":"(Reuters) -Biogen Inc on Thursday mounted a defense of its interactions with U.S. regulators that led to a controversial approval of its new Alzheimer’s treatment, as the company seeks to quell concerns about the drug’s effectiveness.\nThe company recorded nearly $2 million in sales of the drug, which was approved on June 7, in the second quarter, while analysts on average had estimated $3.23 million, according to IBES data from Refinitiv.\nThe decision by the U.S. Food and Drug Administration to approve Aduhelm despite its panel of outside experts recommending against it has drawn criticism, with the agency asking federal investigators to review the process.\n“We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab. A better understanding of the facts is good for everyone involved,” Alfred Sandrock, head of research and development at Biogen, said in an open letter to the Alzheimer’s disease community.\nThe company’s comments about the drug’s approval make it clear that there is “little chance of the controversy abating in the near term,” said Wedbush analyst Laura Chico.\nAduhelm’s $56,000 per year price tag has also spurred lawmakers to launch a probe, with insurers waiting for clarity before starting coverage.\nThe drugmaker expects modest revenue from Aduhelm this year and to ramp up thereafter, adding it was seeing “strong indications of very high initial patient interest as well as increased referrals.”\nBiogen now expects total sales of $10.65 billion to $10.85 billion this year, compared with its prior estimate of $10.45 billion to $10.75 billion.\nThe company’s shares gained 1.1% to $326.50 in early trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}